{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:42:29Z","timestamp":1793817749325,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A27947, DRCPFA-Nov25\/100004"],"award-info":[{"award-number":["A27947, DRCPFA-Nov25\/100004"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The tumor extracellular matrix (ECM) is increasingly recognized as a key driver of immune suppression and therapy resistance in cancer. However, the specific ECM components and mechanisms that create this immunosuppressive environment remain poorly understood, hindering the development of new therapies. Here, we use comprehensive multi omics profiling of triple-negative breast cancer (TNBC), an aggressive and treatment-resistant subtype, to investigate this issue. We report that ECM immunomodulation in TNBC is mediated by post-translational glycan modifications on ECM proteins. Using decellularized human TNBC samples, we show that targeted enzymatic removal of these ECM glycans modifies the tumor immune microenvironment. This modification reprograms tumor-associated myeloid cells toward an immunomodulatory phenotype and improves infiltration of T cells. Notably, ECM desialylation alters selectin and selectin-ligand programs on T cells, consistent with improved trafficking and intratumoral access. In parallel, macrophage\u2013T cell interactions are reshaped, leading to reduced T cell exhaustion. Our findings identify ECM glycan modifications as critical regulators of the innate and adaptive TNBC immune microenvironment. They suggest that targeting ECM glycosylation could offer potential strategies to boost anti-tumor immunity in this aggressive breast cancer subtype.<\/jats:p>","DOI":"10.1038\/s41467-026-73467-5","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:02:50Z","timestamp":1781600570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Glycosylated extracellular matrix drives immune suppression by modulating macrophage-T cell crosstalk in triple-negative breast cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7922-1997","authenticated-orcid":false,"given":"Ludovica","family":"Tarantola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8945-4823","authenticated-orcid":false,"given":"Eleanor J.","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6993-9890","authenticated-orcid":false,"given":"Eleni","family":"Maniati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3022-8924","authenticated-orcid":false,"given":"Katie A.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-4496","authenticated-orcid":false,"given":"Celia","family":"Mart\u00edn-Otal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daire","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithu","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Hirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4128-8354","authenticated-orcid":false,"given":"Marcos","family":"Burger Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-8247","authenticated-orcid":false,"given":"Eliott H.","family":"Puttock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6361-4291","authenticated-orcid":false,"given":"Vinothini","family":"Rajeeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-2274","authenticated-orcid":false,"given":"Pedro","family":"Cutillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-4388","authenticated-orcid":false,"given":"Oscar","family":"Maiques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Soulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Correa de Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-6986","authenticated-orcid":false,"given":"David M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8275-8488","authenticated-orcid":false,"given":"John","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5563-679X","authenticated-orcid":false,"given":"Stuart M.","family":"Haslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8910-5620","authenticated-orcid":false,"given":"Heinz","family":"L\u00e4ubli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3953-1629","authenticated-orcid":false,"given":"Oliver M. T.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"73467_CR1","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Investig. 121, 2750\u20132767 (2011).","journal-title":"J. Clin. Investig."},{"key":"73467_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini, G., De Angelis, C., Licata, L. & Gianni, L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat. Rev. Clin. Oncol. 19, 91\u2013113 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"73467_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1470-2045(19)30689-8","volume":"21","author":"P Schmid","year":"2020","unstructured":"Schmid, P. et al. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 21, 44\u201359 (2020).","journal-title":"Lancet Oncol."},{"key":"73467_CR4","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/jnci\/djae129","volume":"116","author":"R Dent","year":"2024","unstructured":"Dent, R. et al. Neoadjuvant pembrolizumab plus chemotherapy\/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study. J. Natl. Cancer Inst. 116, 1654\u20131663 (2024).","journal-title":"J. Natl. Cancer Inst."},{"key":"73467_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2020","unstructured":"Rafiq, S., Hackett, C. S. & Brentjens, R. J. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat. Rev. Clin. Oncol. 17, 147\u2013167 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"73467_CR6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","volume":"18","author":"M Egeblad","year":"2010","unstructured":"Egeblad, M., Nakasone, E. S. & Werb, Z. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18, 884\u2013901 (2010).","journal-title":"Dev. Cell"},{"key":"73467_CR7","doi-asserted-by":"publisher","unstructured":"Lu, P., Takai, K., Weaver, V. M. & Werb, Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb. Perspect. Biol. 3. https:\/\/doi.org\/10.1101\/cshperspect.a005058 (2011).","DOI":"10.1101\/cshperspect.a005058"},{"key":"73467_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox, T. R. The matrix in cancer. Nat. Rev. Cancer 21, 217\u2013238 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"73467_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup, M. W., Mouw, J. K. & Weaver, V. M. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 15, 1243\u20131253 (2014).","journal-title":"EMBO Rep."},{"key":"73467_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1158\/2159-8290.CD-17-0284","volume":"8","author":"OMT Pearce","year":"2018","unstructured":"Pearce, O. M. T. et al. Deconstruction of a Metastatic Tumor Microenvironment Reveals A Common Matrix Response In Human Cancers. Cancer Discov. 8, 304\u2013319 (2018).","journal-title":"Cancer Discov."},{"key":"73467_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"KM Tharp","year":"2024","unstructured":"Tharp, K. M. et al. Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat. Cancer 5, 1045\u20131062 (2024).","journal-title":"Nat. Cancer"},{"key":"73467_CR12","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cmet.2021.04.017","volume":"33","author":"KM Tharp","year":"2021","unstructured":"Tharp, K. M. et al. Adhesion-mediated mechanosignaling forces mitohormesis. Cell Metab. 33, 1322\u20131341.e1313 (2021).","journal-title":"Cell Metab."},{"key":"73467_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.matbio.2011.10.004","volume":"31","author":"SP Evanko","year":"2012","unstructured":"Evanko, S. P., Potter-Perigo, S., Bollyky, P. L., Nepom, G. T. & Wight, T. N. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol. 31, 90\u2013100 (2012).","journal-title":"Matrix Biol."},{"key":"73467_CR14","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1158\/2767-9764.CRC-23-0548","volume":"4","author":"P Hirani","year":"2024","unstructured":"Hirani, P. et al. Versican Associates With Tumor Immune Phenotype And Limits T-cell Trafficking Via Chondroitin Sulfate. Cancer Res. Commun. 4, 970\u2013985 (2024).","journal-title":"Cancer Res. Commun."},{"key":"73467_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/glycob\/cwy069","volume":"28","author":"OMT Pearce","year":"2018","unstructured":"Pearce, O. M. T. & L\u00e4ubli, H. Cancer immunotherapy. Glycobiology 28, 638\u2013639 (2018).","journal-title":"Glycobiology"},{"key":"73467_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2022.100105","volume":"14","author":"KJ Metcalf","year":"2022","unstructured":"Metcalf, K. J. et al. Immunosuppressive glycoproteins associate with breast tumor fibrosis and aggression. Matrix Biol. 14, 100105 (2022).","journal-title":"Matrix Biol."},{"key":"73467_CR17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3724\/abbs.2024107","volume":"56","author":"Y Cao","year":"2024","unstructured":"Cao, Y., Yi, W. & Zhu, Q. Glycosylation in the tumor immune response: the bitter side of sweetness. Acta Biochim. Biophys. Sin. 56, 1184\u20131198 (2024).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"73467_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38093-5","volume":"14","author":"EH Puttock","year":"2023","unstructured":"Puttock, E. H. et al. Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis. Nat. Commun. 14, 2514 (2023).","journal-title":"Nat. Commun."},{"key":"73467_CR19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.ymthe.2022.01.030","volume":"30","author":"YJ Oh","year":"2022","unstructured":"Oh, Y. J. et al. Antitumor activity of a lectibody targeting cancer-associated high-mannose glycans. Mol. Ther. 30, 1523\u20131535 (2022).","journal-title":"Mol. Ther."},{"key":"73467_CR20","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3389\/fimmu.2015.00500","volume":"6","author":"H Bougherara","year":"2015","unstructured":"Bougherara, H. et al. Real-time imaging of resident T cells in human lung and ovarian carcinomas reveals how different tumor microenvironments control T lymphocyte migration. Front. Immunol. 6, 500 (2015).","journal-title":"Front. Immunol."},{"key":"73467_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI45817","volume":"122","author":"H Salmon","year":"2012","unstructured":"Salmon, H. et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J. Clin. Investig. 122, 899\u2013910 (2012).","journal-title":"J. Clin. Investig."},{"key":"73467_CR22","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","volume":"20","author":"M Bied","year":"2023","unstructured":"Bied, M., Ho, W. W., Ginhoux, F. & Bl\u00e9riot, C. Roles of macrophages in tumor development: a spatiotemporal perspective. Cell Mol. Immunol. 20, 983\u2013992 (2023). ethics.","journal-title":"Cell Mol. Immunol."},{"key":"73467_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07387-4","volume":"9","author":"MC Schmid","year":"2018","unstructured":"Schmid, M. C. et al. Integrin CD11b activation drives anti-tumor innate immunity. Nat. Commun. 9, 5379 (2018).","journal-title":"Nat. Commun."},{"key":"73467_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s42003-020-01359-5","volume":"3","author":"R Beatson","year":"2020","unstructured":"Beatson, R. et al. Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype. Commun. Biol. 3, 644 (2020).","journal-title":"Commun. Biol."},{"key":"73467_CR25","doi-asserted-by":"publisher","first-page":"e22560","DOI":"10.1371\/journal.pone.0022560","volume":"6","author":"S Yang","year":"2011","unstructured":"Yang, S., Liu, F., Wang, Q. J., Rosenberg, S. A. & Morgan, R. A. The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. PLoS ONE 6, e22560 (2011).","journal-title":"PLoS ONE"},{"key":"73467_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112436","volume":"42","author":"JL Hope","year":"2023","unstructured":"Hope, J. L. et al. PSGL-1 attenuates early TCR signaling to suppress CD8(+) T cell progenitor differentiation and elicit terminal CD8(+) T cell exhaustion. Cell Rep. 42, 112436 (2023).","journal-title":"Cell Rep."},{"key":"73467_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1158\/2326-6066.CIR-18-0505","volume":"7","author":"Q Haas","year":"2019","unstructured":"Haas, Q. et al. Siglec-9 regulates an effector memory CD8(+) T-cell subset that congregates in the melanoma tumor microenvironment. Cancer Immunol. Res. 7, 707\u2013718 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"73467_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg3072","volume":"14","author":"B Greco","year":"2022","unstructured":"Greco, B. et al. Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies. Sci. Transl. Med. 14, eabg3072 (2022).","journal-title":"Sci. Transl. Med."},{"key":"73467_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112475","volume":"42","author":"H Egan","year":"2023","unstructured":"Egan, H. et al. Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment. Cell Rep. 42, 112475 (2023).","journal-title":"Cell Rep."},{"key":"73467_CR30","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1158\/0008-5472.CAN-22-3260","volume":"83","author":"K Cao","year":"2023","unstructured":"Cao, K. et al. Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer. Cancer Res. 83, 2171\u20132186 (2023).","journal-title":"Cancer Res."},{"key":"73467_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s42003-021-02934-0","volume":"5","author":"E Rodriguez","year":"2022","unstructured":"Rodriguez, E. et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun. Biol. 5, 41 (2022).","journal-title":"Commun. Biol."},{"key":"73467_CR32","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrm3902","volume":"15","author":"JK Mouw","year":"2014","unstructured":"Mouw, J. K., Ou, G. & Weaver, V. M. Extracellular matrix assembly: a multiscale deconstruction. Nat. Rev. Mol. Cell Biol. 15, 771\u2013785 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"73467_CR33","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1158\/0008-5472.CAN-24-3039","volume":"84","author":"EJ Tyler","year":"2024","unstructured":"Tyler, E. J. & Pearce, O. M. T. Tumor\u2019s digest: macrophage metabolism creates a barrier to T Cells. Cancer Res. 84, 3322\u20133323 (2024).","journal-title":"Cancer Res."},{"key":"73467_CR34","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1158\/0008-5472.CAN-17-3376","volume":"78","author":"C B\u00fcll","year":"2018","unstructured":"B\u00fcll, C. et al. Sialic acid blockade suppresses tumor growth by enhancing T-cell-mediated tumor immunity. Cancer Res. 78, 3574\u20133588 (2018).","journal-title":"Cancer Res."},{"key":"73467_CR35","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","volume":"16","author":"MA Gray","year":"2020","unstructured":"Gray, M. A. et al. Targeted glycan degradation potentiates the anticancer immune response in vivo. Nat. Chem. Biol. 16, 1376\u20131384 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"73467_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.903800","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. IL-6: the link between inflammation, immunity and breast cancer. Front. Oncol. 12, 903800 (2022).","journal-title":"Front. Oncol."},{"key":"73467_CR37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct. Target. Ther. 6, 263 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"73467_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211069012","volume":"10","author":"B Mirlekar","year":"2022","unstructured":"Mirlekar, B. Tumor promoting roles of IL-10, TGF-\u03b2, IL-4, and IL-35: Its implications in cancer immunotherapy. SAGE Open Med. 10, 20503121211069012 (2022).","journal-title":"SAGE Open Med."},{"key":"73467_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep03456","volume":"3","author":"S Cochaud","year":"2013","unstructured":"Cochaud, S. et al. IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1\/2. Sci. Rep. 3, 3456 (2013).","journal-title":"Sci. Rep."},{"key":"73467_CR40","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.4049\/jimmunol.1203141","volume":"190","author":"X Qian","year":"2013","unstructured":"Qian, X. et al. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. J. Immunol. 190, 5894\u20135902 (2013).","journal-title":"J. Immunol."},{"key":"73467_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41568-024-00704-8","volume":"24","author":"JC Ashworth","year":"2024","unstructured":"Ashworth, J. C. & Cox, T. R. The importance of 3D fibre architecture in cancer and implications for biomaterial model design. Nat. Rev. Cancer 24, 461\u2013479 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"73467_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-6-11","volume":"6","author":"PP Provenzano","year":"2008","unstructured":"Provenzano, P. P. et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 6, 11 (2008).","journal-title":"BMC Med."},{"key":"73467_CR43","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.immuni.2016.04.015","volume":"44","author":"R Tinoco","year":"2016","unstructured":"Tinoco, R. et al. PSGL-1 is an immune checkpoint regulator that promotes T cell exhaustion. Immunity 44, 1190\u20131203 (2016).","journal-title":"Immunity"},{"key":"73467_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"73467_CR45","doi-asserted-by":"crossref","unstructured":"Weigert, M. & Schmidt, U. Nuclei instance segmentation and classification in histopathology images with Stardist. In 2022 IEEE International Symposium on Biomedical Imaging Challenges (ISBIC), pp. 1-4 (IEEE, 2022).","DOI":"10.1109\/ISBIC56247.2022.9854534"},{"key":"73467_CR46","doi-asserted-by":"publisher","unstructured":"Wershof, E. et al. A FIJI macro for quantifying pattern in extracellular matrix. Life Sci. Alliance 4. https:\/\/doi.org\/10.26508\/lsa.202000880 (2021).","DOI":"10.26508\/lsa.202000880"},{"key":"73467_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.103102","volume":"5","author":"F Lafor\u00eats","year":"2024","unstructured":"Lafor\u00eats, F., Donnadieu, E. & Balkwill, F. Protocol for real-time monitoring of CD8(+) T and myeloid cell behavior in human high-grade serous ovarian cancer slices. STAR Protoc. 5, 103102 (2024).","journal-title":"STAR Protoc."},{"key":"73467_CR48","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 41, D991\u2013D995 (2013).","journal-title":"Nucleic Acids Res."},{"key":"73467_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207\u2013210 (2002).","journal-title":"Nucleic Acids Res."},{"key":"73467_CR50","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013d552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73467-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73467-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73467-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:02:57Z","timestamp":1781600577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73467-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73467"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73467-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5008"}}